by According to Precedence Research, during the forecast period of 2022 to 2030, the global baby food market is estimated to develop at a compound annual growth rate (CAGR) of 5.54%. The global baby food market was valued at USD 73.88 billion in 2021, and it is predicted to exceed USD 120 billion by 2030. The study investigates several elements and their consequences on the growth of the baby food market.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1710
This report focuses on baby food market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall baby food market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.
Report Scope of the Baby Food Market
| Report Coverage | Details |
| Market Size by 2030 | USD 120 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 5.54% |
| Largest Market | Asia Pacific |
| Online Distribution Channel Segment Growth Rate | 13.2% from 2022 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Category, Types, Distribution Channel, Ingredients, Formulation, Health Benefit, Geography |
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
In-Depth Analysis on Competitive Landscape
The report sheds light on leading manufacturers of baby food, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of baby food has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the baby food market.
Some of the prominent players in the baby food market include:
- Nestlé (Gerber Products Company)
- Danone S.A.
- Reckitt Benckiser (Mead Johnson & Company, LLC)
- Abbott
- Feihe International Inc.
- Fries land Campina
- Bellamy’s Organic
- Kraft Heinz
- HiPP GmbH & Co. Vertrieb KG
- Perrigo
- Arla Food
Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1710
Segments Covered in the Report
By Category
- Organic
- Conventional
By Types
- Milk Formula
- Dried
- Ready-to-Feed
- Other
By Distribution Channel
- Drugstores/ Pharmacies
- Supermarkets/Hypermarkets
- Convenience Store
- Online Channels
- Other Distribution Channels
By Ingredients
- Fats and Oils
- Lactose
- Protein
- Flour
- Flavour Enhancer
- Vitamins & Minerals
- Others
By Formulation
- Powder
- Liquid
By Health Benefit
- Brain & Eye Development
- Muscular Growth
- Bones & Teeth Development
- Blood Enhancement
- Nervous System
- Vascular System
- Body Energy
- Other
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- What value propositions should businesses aim at while making new research and development funding?
- Which regulations will be most helpful for stakeholders to boost their supply chain network?
- Which regions might see the demand maturing in certain segments in near future?
- What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
- Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
- Which government regulations might challenge the status of key regional markets?
- How will the emerging political and economic scenario affect opportunities in key growth areas?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Health Benefit Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Baby Food Market
5.1. COVID-19 Landscape: Baby Food Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Baby Food Market, By Category Type
8.1. Baby Food Market, by Category Type, 2022-2030
8.1.1. Organic
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Conventional
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Baby Food Market, By Types
9.1. Baby Food Market, by Types Type, 2022-2030
9.1.1. Milk Formula
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Dried
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Ready-to-Feed
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Baby Food Market, By Ingredients Type
10.1. Baby Food Market, by Ingredients Type, 2022-2030
10.1.1. Fats and Oils
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Lactose
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Protein
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Flour
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Flavour Enhancer
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Vitamins & Minerals
10.1.6.1. Market Revenue and Forecast (2017-2030)
10.1.7. Others
10.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Baby Food Market, By Formulation Type
11.1. Baby Food Market, by Formulation Type, 2022-2030
11.1.1. Powder
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Liquid
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Baby Food Market, By Distribution Channel
12.1. Baby Food Market, by Distribution Channel, 2022-2030
12.1.1. Drugstores/ Pharmacies
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Supermarkets/Hypermarkets
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Online Channels
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. Convenience Store
12.1.4.1. Market Revenue and Forecast (2017-2030)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Baby Food Market, By Health Benefit
13.1. Baby Food Market, by Health Benefit Type, 2022-2030
13.1.1. Brain & Eye Development
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Muscular Growth
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.3. Bones & Teeth Development
13.1.3.1. Market Revenue and Forecast (2017-2030)
13.1.4. Blood Enhancement
13.1.4.1. Market Revenue and Forecast (2017-2030)
13.1.5. Nervous System
13.1.5.1. Market Revenue and Forecast (2017-2030)
13.1.6. Vascular System
13.1.6.1. Market Revenue and Forecast (2017-2030)
13.1.7. Body Energy
13.1.7.1. Market Revenue and Forecast (2017-2030)
13.1.8. Others
13.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Baby Food Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Category (2017-2030)
14.1.2. Market Revenue and Forecast, by Types (2017-2030)
14.1.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.1.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.1.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.1.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Category (2017-2030)
14.1.7.2. Market Revenue and Forecast, by Types (2017-2030)
14.1.7.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.1.7.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.1.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.1.8.1. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Category (2017-2030)
14.1.9.2. Market Revenue and Forecast, by Types (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.1.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.1.11. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Category (2017-2030)
14.2.2. Market Revenue and Forecast, by Types (2017-2030)
14.2.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.2.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.2.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Category (2017-2030)
14.2.8.2. Market Revenue and Forecast, by Types (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.2.9. Market Revenue and Forecast, by Formulation (2017-2030)
14.2.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.10.1. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Category (2017-2030)
14.2.11.2. Market Revenue and Forecast, by Types (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.2.12. Market Revenue and Forecast, by Formulation (2017-2030)
14.2.13. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.14. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Category (2017-2030)
14.2.15.2. Market Revenue and Forecast, by Types (2017-2030)
14.2.15.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.2.15.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.2.16. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.16.1. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Category (2017-2030)
14.2.17.2. Market Revenue and Forecast, by Types (2017-2030)
14.2.17.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.2.17.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.2.18. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.18.1. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Category (2017-2030)
14.3.2. Market Revenue and Forecast, by Types (2017-2030)
14.3.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.3.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.3.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Category (2017-2030)
14.3.7.2. Market Revenue and Forecast, by Types (2017-2030)
14.3.7.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.3.7.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.3.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.9. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Category (2017-2030)
14.3.10.2. Market Revenue and Forecast, by Types (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.3.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.11.1. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Category (2017-2030)
14.3.12.2. Market Revenue and Forecast, by Types (2017-2030)
14.3.12.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.3.12.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.3.12.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.12.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Category (2017-2030)
14.3.13.2. Market Revenue and Forecast, by Types (2017-2030)
14.3.13.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.3.13.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.3.13.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.13.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Category (2017-2030)
14.4.2. Market Revenue and Forecast, by Types (2017-2030)
14.4.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.4.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.4.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Category (2017-2030)
14.4.7.2. Market Revenue and Forecast, by Types (2017-2030)
14.4.7.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.4.7.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.4.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.9. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Category (2017-2030)
14.4.10.2. Market Revenue and Forecast, by Types (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.4.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.12. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Category (2017-2030)
14.4.13.2. Market Revenue and Forecast, by Types (2017-2030)
14.4.13.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.4.13.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.4.13.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.13.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Category (2017-2030)
14.4.14.2. Market Revenue and Forecast, by Types (2017-2030)
14.4.14.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.4.14.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.4.14.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.14.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Category (2017-2030)
14.5.2. Market Revenue and Forecast, by Types (2017-2030)
14.5.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.5.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.5.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Category (2017-2030)
14.5.7.2. Market Revenue and Forecast, by Types (2017-2030)
14.5.7.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.5.7.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.5.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5.8.1. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Category (2017-2030)
14.5.9.2. Market Revenue and Forecast, by Types (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5.9.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
Chapter 15. Company Profiles
15.1. Nestlé (Gerber Products Company)
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Danone S.A.
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Reckitt Benckiser (Mead Johnson & Company, LLC)
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Abbott
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Feihe International Inc.
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Fries land Campina
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Bellamy’s Organic
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Kraft Heinz
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. HiPP GmbH & Co. Vertrieb KG
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Perrigo
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
15.11. Arla Food
15.11.1. Company Overview
15.11.2. Product Offerings
15.11.3. Financial Performance
15.11.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1710
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
